Cidm (CIDM) is a leading provider of software-defined networking solutions that enable companies to connect and manage their networks with ease. The company provides its customers with the cloud-based networking platform, which leverages industry-leading technology and provides unmatched flexibility and scalability.
What is cidm stock?
Cidm stock ( NASDAQ : CIDM) is a biotechnology company that specializes in developing and commercializing novel therapies for central nervous system disorders. The company’s products include cannabidiol (CBD), which is a non-psychoactive cannabinoid compound found in cannabis, and its subsidiary, Cervantes Therapeutics, Ltd., develops novel CBD therapeutic products. In addition to its clinical programs, the company also explores the potential use of cannabinoids in other medical applications.
What is cidm stock price?
The stock price of cidm stock was $10.68 as of Feb. 22, 2019.
What is cidm stock price?
Cidm Corporation (NASDAQ: CIDM) is a biopharmaceutical company that discovers, develops, manufactures and commercializes novel therapeutics for the treatment of serious diseases. The company’s product pipeline focuses on the development of novel antiviral agents to treat respiratory viruses including pandemic influenza A (H1N1), as well as other important diseases such as hepatitis C virus (HCV).
In October 2017, Cidm announced positive results from an early stage clinical study evaluating its candidate HCV vaccine. The study showed that the vaccine was safe and induced a durable immune response in healthy volunteers. The company plans to initiate a Phase III clinical study in late-2018 or early 2019 in order to confirm the vaccine’s efficacy and safety.
The stock price of Cidm Corporation (NASDAQ: CIDM) was $11.02 per share as of September 30, 2018.
What is cidm stock quote?
cidm stock price is Rs. 296.95 on 1 Jul 2018. It has a market capitalization of Rs. 1,522 crore and a P/E ratio of 13.89. Cidm is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
Cidm was founded in 2002 as an affiliate of Infosys Limited with the objective of providing technology-enabled business process outsourcing services to small and medium enterprises (SMEs). The company has since grown rapidly, and now employs over 6,000 people spanning 22 countries across six continents.
In 2017, cidm announced that it had entered into an agreement with Hudson Corporation to provide US$500 million in financing for its growth plans globally. This included the announcement of an expansion into new geographies such as India and China, as well as an increase in headcount from 6,000 to 7,500 employees by 2020.
Today, cidm provides technology-enabled business process outsourcing services to a wide range of clients including banks, retail organizations, airlines and large businesses such as ING Group and Amazon.
What are the latest news about cidm stock?
The current stock price for Cidm Corporation is $10.68 and the latest news about cidm stock is that the company has released earnings results for the quarter ended March 31, 2018. This news was released on May 8th and reported a net income of $3.6 million, or $0.11 per share on revenue of $35.8 million, compared to net income of $2.9 million, or $0.08 per share on revenue of $32.4 million in the prior year period. The company also announced that its Board of Directors has declared a cash dividend of $0.12 per share on common stock and will pay this dividend on June 12, 2018 to shareholders of record as of the close of business on May 15, 2018.
What are the cidm stock basics?
The cidm stock basics provide information on the stock price, quote and news for the company. The latest news and updates can be found here.
Cidm Corporation (OTCQB: CIDM) is a biopharmaceutical company focused on discovering, developing, manufacturing and marketing novel treatments for chronic inflammatory diseases. The company’s pipeline of products includes investigational therapies for Crohn’s disease and ulcerative colitis, as well as a leading product candidate for psoriasis. Cidm has both clinical-stage programs and an early-stage science platform. The company completed Phase 3 clinical trials in 2017 for its lead product candidate, cidmavir (Schering-Plough).
What does cidm stock price mean?
What does cidm stock price mean?
The cidm stock price is the price at which shares of the company are traded on a stock exchange. The current stock price can be found on the company’s website or on various financial websites.
What is cidm news?
What is CIDM news?
Cidm, Inc. (CIDM) is a publicly traded company that manufactures and sells products for the cannabis industry. The Company’s products include extraction systems, water filtration products and distillation accessories for the cultivation and manufacturing of cannabinoid-based products. It also provides support services related to its products, including sales, marketing and customer service.
The Company was founded in 2014 and is headquartered in San Diego.
Conclusion
Looking for the latest news and stock prices on cidm? Look no further than our comprehensive cidm stock overview. Here you’ll find all the latest information on stock price, quote and news, so you can make informed decisions about which stocks to buy or sell.
